Gilead's remdesivir shows promise in COVID-19 study on monkeys

Remdesivir is the first drug to show improvement in COVID-19 in human trials, and its progress in clinical studies is being closely watched as nations look for a treatment for the disease.

Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.

Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.

(photo credit: GILEAD SCIENCES INC/HANDOUT VIA REUTERS)

ByREUTERS

JUNE 9, 2020 15:54